Table 2.
Variable | ITT (n = 50) |
---|---|
Age | 47.2 (15.7) |
50.0 (19.0; 77.0) | |
n = 50 | |
Sex | |
Male | 30 (60.0%) |
Female | 20 (40.0%) |
Diabetes duration | 21.4 (13.1) |
16.8 (1.1; 60.7) | |
n = 50 | |
BMI (kg/m2) | 25.5 (4.2) |
24.7 (19.3; 35.9) | |
n = 49 | |
Smoking | 8 (16.0%) |
HbA1c (%, NGSP) | 8.18 (1.40) |
8.10 (5.54; 12.58) | |
n = 50 | |
A/C ratio | 2.02 (4.09) |
0.90 (0.20; 20.90) | |
n = 43 | |
Insulin delivery | |
CSII | 13 (26.0%) |
MDI | 37 (74.0%) |
Insulin dose | 47.8 (25.0) |
40.0 (15.0; 136.0) | |
n = 50 | |
Systolic blood pressure | 128.7 (14.6) |
128.0 (104.0; 166.0) | |
n = 49 | |
Diastolic blood pressure | 71.4 (9.3) |
72.0 (43.0; 93.0) | |
n = 49 | |
Average number of hypoglycemia per month | 6.64 (6.99) |
4.00 (0.00; 30.00) | |
n = 50 | |
Previous myocardial infarction | 0 (0.0%) |
Previous stroke | 1 (2.0%) |
Previous amputation | 1 (2.0%) |
Previous foot ulcers | 0 (0.0%) |
Current foot ulcers | 4 (8.0%) |
Previous retinopathy | 3 (6.0%) |
For categorical variables n (%) is presented.
For continuous variables mean (SD)/median (Min; Max)/n is presented.
A/C, albumin/creatinine; CSII, continuous subcutaneous insulin infusion; HbA1c, hemoglobin A1c; ITT, intention-to-treat; MDI, multiple daily insulin injections; NGSP, National Glycohemoglobin Standardization Program.